Skip to content

Clinical trials

Observational Rare Diseases trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Rare Diseases Phase: Observational Country / region: United Kingdom Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20061
20071
20131
20171
20181
20201
20231
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Not yet recruiting2
Enrolling by invitation1
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Associazione Angela Serra per la ricerca sul cancro2
Friedreich's Ataxia Research Alliance1
National Center for Research Resources (NCRR)1
NightstaRx Ltd, a Biogen Company1
Prof. Valérie Mc Lin1
Ultragenyx Pharmaceutical Inc1
University College, London1
University of Exeter1
University of Manchester1
Zymenex A/S1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Rare Diseases11
Ataxia2
Friedreich Ataxia2
Genetic Diseases, Inborn2
Congenital Abnormalities1
Congenital Portosystemic Shunt1
Dysostoses1
Hearing Loss1
Hematologic Diseases1
Hepatic Encephalopathy1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.